Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Receivables: 2020-2022

Historic Receivables for Relay Therapeutics (RLAY) over the last 3 years, with Dec 2022 value amounting to $5.2 million.

  • Relay Therapeutics' Receivables fell 95.90% to $211,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $10.7 million, marking a year-over-year decrease of 46.67%. This contributed to the annual value of $5.2 million for FY2022, which is 5.65% up from last year.
  • Latest data reveals that Relay Therapeutics reported Receivables of $5.2 million as of FY2022, which was up 5.65% from $4.9 million recorded in FY2021.
  • Over the past 5 years, Relay Therapeutics' Receivables peaked at $82.7 million during FY2020, and registered a low of $4.9 million during FY2021.
  • In the last 3 years, Relay Therapeutics' Receivables had a median value of $5.2 million in 2022 and averaged $30.9 million.
  • Per our database at Business Quant, Relay Therapeutics' Receivables tumbled by 94.02% in 2021 and then climbed by 5.65% in 2022.
  • Relay Therapeutics' Receivables (Yearly) stood at $82.7 million in 2020, then plummeted by 94.02% to $4.9 million in 2021, then rose by 5.65% to $5.2 million in 2022.